PATENT CLAIM ANALYSIS

Application Number: 15984028
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "178000"]

Abstract:
Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum plasma testosterone levels over an extended period.

Claim (Index 14):
The method of  claim 1 , wherein steps a.-d. are repeated until the plasma testosterone concentration in the subject is between about 350 and about 800 ng/dL.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 93.0
- Lexical Diversity: 1.21429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12758770', '13584958', '15107492', '15723985', '14691229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.823030792816339
- 35 USC 102 Novelty (BERT): 0.5452573103990804
- Combined Prediction Score: 0.7952534445746131
- Mean Citation Score: 385.839508
- Max Citation Score: 404.2631
- Similarity Product: 263.9303824034631

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test